Libra Infusions (DHA:LIBRAINFU) Other Current Liabilities: BDT8.01 Mil (As of Dec. 2020)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:LIBRAINFU Libra Infusions Ltd DHA:LIBRAINFU
20 GF Score
Price BDT573.70
View Full Analysis

What is Libra Infusions Other Current Liabilities?

Libra Infusions DHA:LIBRAINFU +1.47% 20 Other Current Liabilities is BDT8.01 Mil as of Dec. 2020. GuruFocus rates DHA:LIBRAINFU with a GF Score™ of 20/100.

Libra Infusions's other current liabilities for the quarter that ended in Dec. 2020 was BDT8.01 Mil.

Libra Infusions's quarterly other current liabilities stayed the same from . 20 (BDT0.00 Mil) to . 20 (BDT0.00 Mil) but then increased from . 20 (BDT0.00 Mil) to Dec. 2020 (BDT8.01 Mil).

Libra Infusions's annual other current liabilities declined from Jun. 2019 (BDT21.22 Mil) to Jun. 2020 (BDT10.64 Mil) and declined from Jun. 2020 (BDT10.64 Mil) to Jun. 2021 (BDT8.23 Mil).

Libra Infusions Other Current Liabilities Related Terms

Libra Infusions Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Libra Infusions's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Libra Infusions Other Current Liabilities Chart

Libra Infusions Annual Data
Trend Jun19 Jun20 Jun21
Other Current Liabilities
21.22 10.64 8.23

Libra Infusions Quarterly Data
Dec20
Other Current Liabilities 8.01
DHA:LIBRAINFU
20GF Score
Libra Infusions Ltd DHA:LIBRAINFU
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Libra Infusions Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of BDT8.01 Mil mean?
Libra Infusions (DHA:LIBRAINFU) has a Other Current Liabilities of BDT8.01 Mil as of Dec. 2020. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Libra Infusions.
Is Libra Infusions' Other Current Liabilities too high?
Libra Infusions' current Other Current Liabilities is BDT8.01 Mil. Overall, Libra Infusions has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Libra Infusions' Other Current Liabilities compare to SECI and LENSF?
Libra Infusions' Other Current Liabilities of BDT8.01 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Libra Infusions. Libra Infusions's current Other Current Liabilities is BDT8.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Libra Infusions stock overvalued right now?
Libra Infusions (DHA:LIBRAINFU) has a current Other Current Liabilities of BDT8.01 Mil. The current Other Current Liabilities is BDT8.01 Mil. Libra Infusions' overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Libra Infusions (DHA:LIBRAINFU), the current Other Current Liabilities is BDT8.01 Mil as of Dec. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Libra Infusions Business Description

Address I/7, Mirpur Industrial Estate, Rupnagar, Section-2, Dhaka, BGD, 1216
Libra Infusions Ltd is engaged in manufacturing intravenous fluids. It provides products which are used for medical purposes involving surgical operations, loss of blood, weakness, and general hospitalization.
20GF Score

Get the complete analysis for DHA:LIBRAINFU

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT573.70
Price